News

Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...
The Chennai Peripheral Ring Road (CPRR), a 132.87 km six-lane expressway, is set to transform connectivity in Chennai by easing traffic congestion and linking key highways. Expected to be completed by ...
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...
A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...
Novo Nordisk (NVO) announced on Saturday that a late-stage trial for its popular weight loss therapy Ozempic in adults with type 2 diabetes and a vascular disorder known as peripheral artery ...
Semaglutide, a GLP-1 receptor agonist, improves glycaemic control and cardiovascular outcomes in patients with type 2 diabetes and those with cardiovascular disease, including peripheral artery ...
Those outcomes included heart attack, stroke, unstable angina (chest pain that results from restricted blood flow to the heart), peripheral arterial disease (narrowed blood vessels in the arms or ...
Bonaca MC, Catarig AM, Houlind K, et al., for the STRIDE Trial Investigators. Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a ...
Worldwide, TB killed an estimated 1.25 million people in 2023, making it the leading infectious disease killer in the ... using the map below. The interactive map shows three-year average ...
A scientific statement has been published by the AHA regarding sex differences in patients with peripheral vascular disease. The American Heart Association (AHA) released a Scientific Statement in ...